Buscar | Mạng xã hội kotra-hanoi.org.vn

KUMUD SINGH agrega un archivo Health
2026-03-24 11:55:47 -

Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%
According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...

0 Commentarios 0 Acciones 1113 Views

Please log in to like, share and comment!
KUMUD SINGH agrega un archivo Health
2026-03-24 11:59:58 -

Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%
According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...

0 Commentarios 0 Acciones 984 Views

Please log in to like, share and comment!
Karls Scott agrega un archivo Health
2026-04-14 06:40:58 -

Market Opportunities in Glaucoma Drug Development Industry
Understanding Glaucoma in the Modern Healthcare Landscape Glaucoma is a progressive eye condition that remains one of the leading causes of irreversible blindness worldwide. Often referred to as the “silent thief of sight,” it typically advances without noticeable warning signs until significant vision loss has already occurred. Central to the condition is damage to the optic nerve,...

0 Commentarios 0 Acciones 479 Views

Please log in to like, share and comment!
KUMUD SINGH agrega un archivo Health
2026-03-30 10:08:29 -

RdRp Inhibitor Market to Reach USD 521.68 Million by 2028 | CAGR 8.2%
According to a newly published market research report by 24LifeSciences, global RdRp inhibitor market was valued at USD 352.14 million in 2023 and is projected to reach USD 521.68 million by 2028, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2024-2028. RNA-dependent RNA polymerase (RdRp) inhibitors represent a critical antiviral therapy class that prevents...

0 Commentarios 0 Acciones 729 Views

Please log in to like, share and comment!